The Utrecht experience with different treatment strategies in early rheumatoid arthritis

Clinical and Experimental Rheumatology

Volumn 21, Issue 5 SUPPL. 31, 2003, Pages

  Verstappen, S M M ^a   Jacobs, J W G ^b   Bijlsma, J W J ^b   van Albada Kuipers, G A ^b   Blaauw, A A M ^b   van Booma Frankfort, C ^b   ter Borg, E J ^b   Haanen, H C M ^b   Heurkens, A H M ^b   Hofman, D M ^b   Kruize, A A ^b   Schenk, Y ^b   van der Veen, M J ^b   Verhoef, C M ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NONE

Author keywords

Efficacy; Pyramid strategy; Rheumatoid arthritis; Toxicity; Treatment

Indexed keywords

ANTIRHEUMATIC AGENT; AURANOFIN; GOLD; HYDROXYCHLOROQUINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; SALAZOSULFAPYRIDINE;

ANEMIA; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG WITHDRAWAL; EXPERIENCE; GASTROINTESTINAL DISEASE; HEADACHE; HUMAN; INDIVIDUALIZATION; JOINT RADIOGRAPHY; KIDNEY DISEASE; LIVER DISEASE; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; NETHERLANDS; PAIN ASSESSMENT; PATIENT CARE; PHYSICAL DISABILITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SKIN DISEASE; TREATMENT OUTCOME; VERTIGO;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYCHLOROQUINE; MALE; METHOTREXATE; MIDDLE AGED; NETHERLANDS; ORGANOGOLD COMPOUNDS; PAIN MEASUREMENT; RANGE OF MOTION, ARTICULAR; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 10744220469     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. van der HEIDE A, JACOBS JW, BIJLSMA JW, et al.: The effectiveness of early treatment with "second-line" antirheumatic drugs. A randomized, controlled trial. Ann Intern Med 1996; 124: 699-707.
2. VERSTAPPEN SMM, JACOBS JWG, BIJLSMA JWJ, et al.: Five year follow-up of RA-patients after early treatment with DMARDs versus treatment according to the pyramid approach in the first year. Arthritis Rheum 2003; 48: 1797-807.
3. van JAARSVELD CH, JACOBS JW, van der VEEN MJ, et al.: Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial. On behalf of the Rheumatic Research Foundation Utrecht, The Netherlands. Ann Rheum Dis 2000; 59: 468-77.
4. van JAARSVELD CHM, JAHANGIER ZN, JACOBS JWG, et al.: Toxicity of anti-rheumatic drugs in a randomized clinical trial of early rheumatoid arthritis. Rheumatology 2000; 39: 1374-82.